Evidence map›Paper›PMID 19767614›Full record

ArticleNucleic acids research2009

Demonstration of all-or-none loss of imprinting in mRNA expression in single cells.

Andreas I Diplas, Jianzhong Hu, Men-Jean Lee, Yula Y Ma, Yin L Lee, Luca Lambertini, Jia Chen, James G Wetmur

Abstract read
In one paragraph

Article in Nucleic acids research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andreas I DiplasDepartment of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.
Jianzhong Hu
Men-Jean Lee
Yula Y Ma
Yin L Lee
Luca Lambertini
Jia Chen
James G Wetmur

Funding

Immune Function and Biodefense in Immunocrompromised PopulationsN01AI50028 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MORAN, THOMAS · 2007 to 2010
$11.2M
PRENATAL PCB EXPOSURE &NEURODEVELOPMENTAL OUTCOMES IN ADOLESCENCE &ADULTHOODP01ES009584 · NIEHS · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI WOLFF, MARY S · 1999 to 2009
$7.3M
IMMUNE FUNCTION AND BIODEFENSE IN CHILDREN ELDERLY AND IMMUNOCOMPROMIS-266050028N01AI050028 · NIAID · MT SINAI SCH OF MEDICINE · PI MORGAN, THOMAS · 2005 to 2006
–
NIAID NIH HHS N01 AI50028NIEHS NIH HHS P01 ES09584
6 · The paper itself

Abstract

Loss of imprinting (LOI) is the reactivation of the silenced allele of an imprinted gene, leading to perturbation of monoallelic expression. We tested the hypothesis that LOI of PLAGL1, a representative maternally imprinted gene, occurs through an all-or-none process leading to a mixture of fully imprinted and nonimprinted cells. Herein using a quantitative RT-PCR-based experimental approach, we measured LOI at the single cell level in human trophoblasts and demonstrated a broad distribution of LOI among cells exhibiting LOI, with the mean centered at approximately 100% LOI. There was a significant (P < 0.01) increase in expression after 2 days of 5-aza-2'-deoxycytidine (AZA) treatment and a significant (P < 0.01) increase in LOI after both 1 and 2 days of AZA treatment, while the distribution remained broad and centered at approximately 100% LOI. We propose a transcriptional pulsing model to show that the broadness of the distribution reflects the stochastic nature of expression between the two alleles in each cell. The mean of the distribution of LOI in the cells is consistent with our hypothesis that LOI occurs by an all-or-none process. All-or-none LOI could lead to a second distinct cell population that may have a selective advantage, leading to variation of LOI in normal tissues, such as the placenta, or in neoplastic cells.

Indexed as

Genomic ImprintingAllelesAzacitidineCell Cycle ProteinsCells, CulturedDecitabineGene ExpressionHumansHydroxamic AcidsRNA, MessengerTranscription FactorsTrophoblastsTumor Suppressor ProteinsAzacitidineCell Cycle ProteinsDecitabineHydroxamic AcidsPLAGL1 protein, humanRNA, MessengerTranscription Factorstrichostatin ATumor Suppressor Proteins

Identifiers

PMID19767614
PMCPMC2790885

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.